Zenagamtide for diabetes and weight loss
Part of Hormones & metabolism clinical trials.
This study compares a new once-weekly injection to lower blood sugar levels against a standard daily injection in people with type 2 diabetes who are at high risk for heart problems. It aims to find out if the new medicine is more effective in managing blood sugar and body weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years or older.
- You take 1 to 3 diabetes pills to control your blood sugar.
- You have been diagnosed with type 2 diabetes at least 6 months ago.
- You have had a heart attack or stroke, have heart disease, or have kidney disease.
- You have not been treated with insulin for diabetes for a long time in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new once-daily injection (LC-Z300-01) to see if it can lower blood sugar safely in people with type 2 diabetes. It may be a good option if your current diabetes medications aren't controlling your blood sugar as well as you'd like.
This study tests how a new injectable weight loss drug affects the way the body processes metformin, a common diabetes medication. It is for Chinese adults who are overweight or obese.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This trial tests an investigational medication (HS-20094) for people with type 2 diabetes. It aims to see if it can help control blood sugar and possibly support weight loss.
This study is testing a new tablet called Zenagamtide to help people with extra body weight lose weight. It's for adults who are not diabetic and haven't used similar weight loss drugs before.
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.